Advancing Pharmaceutical Quality – What’s New, What’s Next?

Recorded on March 18, 2021, this panel discussion covered what’s new with ISPE’s Advancing Pharmaceutical Quality Program, FDA updates on quality metrics pilots and quality management maturity, insights on the latest pharmaceutical industry operational excellence benchmarks, and practical strategies for building cultural excellence to support enhanced quality outcomes. Our panel of speakers included:
- Nuala Calnan, PhD, CEO, BioPharm Excel
- Tami Frederick, Sr. Director, Corporate Quality and Cultural Excellence, Perrigo
- Thomas Friedli, Director, Institute of Technology Management, St. Gallen University
- Alex Viehmann, Director, Division of Quality Intelligence II, FDA, CDER, Office of Pharmaceutical Quality